Literature DB >> 3919091

Structural and functional characterization of IL 2 receptors on activated human B cells.

A W Boyd, D C Fisher, D A Fox, S F Schlossman, L M Nadler.   

Abstract

After activation, B cells express the IL 2 receptor as determined by their reactivity with monoclonal anti-IL 2 receptor antibodies. In this report we show that anti-IL 2 receptor antibodies precipitated comparable 60,000 to 65,000 dalton proteins from highly purified B and T cells. Limited peptide mapping suggested that the receptors on B and T cells were identical. Moreover, activated B cells could be induced to proliferate by IL 2, but not to secrete Ig. Anti-IL 2R antibody blocked the effect of IL 2 but not the proliferative response induced by B cell growth factor (BCGF), suggesting independent growth factor receptors. Investigation of the kinetics of the B cell response to growth factor indicated that BCGF acts within 24 hr, whereas IL 2 was virtually devoid of activity for 48 hr. Nevertheless, after 72 to 96 hr, the effect of IL 2 was equal to or greater than that obtained with BCGF. These studies suggest that the initial stages of B cell proliferation involves a sequential interaction of BCGF and IL 2 with their respective receptors.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3919091

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  cDNA cloning of ovine interleukin 2 by PCR.

Authors:  J C Goodall; D C Emery; A C Perry; L S English; L Hall
Journal:  Nucleic Acids Res       Date:  1990-10-11       Impact factor: 16.971

2.  Expression of Tac antigen in B cell lymphomas.

Authors:  G Laurent; T Al Saati; D Olive; J C Laurent; P Poncelet; G Delsol
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

3.  Proliferation and immunoglobulin synthesis of peripheral blood mononuclear cells from patients with chronic liver disease stimulated by Staphylococcus aureus Cowan 1 and interleukin 2.

Authors:  S Kakumu; A Fuji; Y Ohtani; K Murase; H Hirofuji; H Tahara
Journal:  Gastroenterol Jpn       Date:  1987-06

4.  Immunophenotypic profile of CNS lymphoma: a review of eighteen cases.

Authors:  R Bashir; A Freedman; N Harris; K Bain; L Nadler; F Hochberg
Journal:  J Neurooncol       Date:  1989-09       Impact factor: 4.130

5.  Cloning, sequence, and expression of bovine interleukin 2.

Authors:  D P Cerretti; K McKereghan; A Larsen; M A Cantrell; D Anderson; S Gillis; D Cosman; P E Baker
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

6.  IL-2 enhances polyclonal IgM but not IgM-rheumatoid factor synthesis by activated human peripheral blood B cells.

Authors:  M Callaghan; A Whelan; C Feighery; B Bresnihan
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

7.  Direct induction of human B-cell differentiation by recombinant interleukin-2.

Authors:  S Romagnani; G Del Prete; M G Giudizi; R Biagiotti; F Almerigogna; A Tiri; A Alessi; M Mazzetti; M Ricci
Journal:  Immunology       Date:  1986-05       Impact factor: 7.397

8.  T cell function in systemic lupus erythematosus: normal production of and responsiveness to interleukin 2.

Authors:  A M Draeger; A J Swaak; H G van den Brink; L A Aarden
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

9.  Human T cell clones reactive with hepatitis B virus (HBV) surface antigen from a HBV vaccine recipient.

Authors:  A Nonomura; G Ohta
Journal:  Gastroenterol Jpn       Date:  1987-04

10.  Immunophenotyping of non-Hodgkin's lymphoma. Correlation with relapse-free survival.

Authors:  H J Schuurman; W Huppes; L F Verdonck; J Van Baarlen; J A Van Unnik
Journal:  Am J Pathol       Date:  1988-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.